Drugs / Fumaric acid

Trials 2 · a red edge is where a trial was stopped

2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT02955693 Sep → Oct 2016 psoriasis Almirall, S.A. Completed No outcome recorded
Phase 21 trial
Phase 2 NCT01352988 Jul 2011 → Oct 2013 cutaneous lupus erythematosus University Hospital Muenster Completed No outcome recorded
Also used as a comparator or background therapy in 4 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03255382 Comparator Aug 2017 → Jul 2018 psoriasis AbbVie Completed No outcome recorded
Phase 3 NCT02951533 Comparator Dec 2016 → Sep 2017 psoriasis Janssen-Cilag GmbH Completed No outcome recorded
Phase 3 NCT02474082 Comparator Apr 2015 → Jun 2016 psoriasis Novartis Pharmaceuticals Completed No outcome recorded
Phase 3 NCT01321164 Comparator Apr 2011 → Dec 2013 psoriasis Medical University of Vienna Completed No outcome recorded

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Fumaric acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT02474082
Known as 2-butenedioic acid, (e)- ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Known as Allomaleic-acid ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Known as Boletic-acid ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Known as E-297 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Known as FEMA NO. 2488 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Known as Fumaderm ClinicalTrials.gov intervention name — accepted as the source's own label NCT02955693
1

NCT03255382

Known as Fumaric acid esters ClinicalTrials.gov intervention name — accepted as the source's own label NCT01352988
2

NCT02951533

NCT01321164

Known as Fumaricum acidum ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Known as INS NO.297 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Known as INS-297 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Known as NSC-2752 ChEMBL registry synonym — accepted as the source's own label CHEMBL503160
Modality Small molecule CHEMBL503160
Route Oral “Monotherapy, Capsules, schema therapy, 1 to 3 times a day, 6 months” NCT01321164